Ingevity Corporation $NGVT Shares Sold by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. trimmed its stake in shares of Ingevity Corporation (NYSE:NGVT) by 36.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,705 shares of the company’s stock after selling 8,584 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Ingevity were worth $870,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of NGVT. AQR Capital Management LLC lifted its position in shares of Ingevity by 10.9% during the 1st quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock valued at $518,000 after acquiring an additional 1,323 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Ingevity by 5.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock valued at $863,000 after acquiring an additional 1,080 shares during the period. Empowered Funds LLC lifted its position in shares of Ingevity by 12.9% during the 1st quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock valued at $205,000 after acquiring an additional 594 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Ingevity by 311.8% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock valued at $23,769,000 after acquiring an additional 454,579 shares during the period. Finally, Jane Street Group LLC lifted its position in shares of Ingevity by 306.1% during the 1st quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock valued at $3,519,000 after acquiring an additional 66,995 shares during the period. 91.59% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on NGVT shares. BMO Capital Markets reissued an “outperform” rating and set a $83.00 price objective on shares of Ingevity in a research note on Monday, March 2nd. Weiss Ratings reissued a “sell (d-)” rating on shares of Ingevity in a research note on Tuesday, April 21st. Jefferies Financial Group reissued a “buy” rating and set a $82.00 price objective on shares of Ingevity in a research note on Thursday, February 26th. Wells Fargo & Company raised their price objective on shares of Ingevity from $65.00 to $75.00 and gave the stock an “equal weight” rating in a research note on Friday, February 27th. Finally, Wall Street Zen cut shares of Ingevity from a “buy” rating to a “hold” rating in a research note on Saturday, April 4th. Two investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $80.00.

Ingevity Stock Up 1.0%

NGVT stock opened at $77.85 on Thursday. The stock has a market capitalization of $2.75 billion, a P/E ratio of -16.74 and a beta of 1.24. The company has a debt-to-equity ratio of 39.10, a quick ratio of 0.79 and a current ratio of 1.33. Ingevity Corporation has a one year low of $36.47 and a one year high of $79.29. The company has a 50 day moving average price of $71.14 and a two-hundred day moving average price of $64.01.

Ingevity (NYSE:NGVT) last released its earnings results on Wednesday, May 6th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $0.84 by $0.31. The firm had revenue of $258.00 million during the quarter, compared to analysts’ expectations of $254.73 million. Ingevity had a negative net margin of 13.51% and a positive return on equity of 126.25%. Ingevity’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.01 EPS. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. As a group, sell-side analysts expect that Ingevity Corporation will post 5.05 EPS for the current year.

Ingevity Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.